The abrupt change in the U.S. childhood vaccine schedule from 17 vaccines to 11 belies promises to the American people that ...

A recent randomised controlled trial showed that proton pump inhibitors (PPIs), compared with histamine-2 receptor antagonists (H2RAs), induce greater gut microbiome alterations and oral-to-gut ...

Novel immunotherapy combination regimen brings together two complementary therapies to improve outcomes for people living with multiple myeloma as early as second line1 ...

ArriVent BioPharma's furmonertinib demonstrates robust efficacy, CNS penetration, and tolerability in early trials. Read why ...

STUDENTS of late-20th-century politics and history might recall that the term ‘Lost Decade’ is used to describe the 1980s in ...

Dr Eliane Bodanese, an engineering lecturer at Queen Mary University, was twice rejected for a promotion which was instead ...

The efficiency and quality of the business regulatory environment can vary substantially across different locations within a ...

We are, all of us, individuals. One-size-fits-all is for knit gloves. When it comes to swing metrics, don't trust anything ...

Organisation of African, Caribbean and Pacific States (OACPS), German Federal Ministry for Economic Cooperation and Development (BMZ), Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ), ...

Takeda (TSE:4502/NYSE:TAK) today announced positive topline results for the two pivotal Phase 3 randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib ...

Strong adherence and safety. Long-term cost savings depend heavily on patient adherence. While twice-daily dosing may pose some risk, its safety profile and novel mechanism—targeting NMDA and sigma-1 ...

Nature Medicine asked leading researchers to name their top clinical trial for 2026, from long-awaited vaccines for infectious diseases to new treatments for advanced cancers and long COVID BriaCell’s ...